Related Experiment Video
Updated: Apr 14, 2026
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Nanoparticles (NPs) as a Cutting-Edge Therapeutic Strategy and Their Current Status in Tuberculosis (TB): A
Krati Shukla1, Vasanth S2, Rakhi Mishra3
1Department of Pharmaceutics, School of Pharmacy, JSS University, Noida, India.
Objective:
The objective of this study is to explore the current status and therapeutic potential of nanoparticles (NPs) as a cutting-edge strategy for the treatment of tuberculosis (TB).
Background:
NPs have emerged as a promising drug delivery system (DDS) due to their ability to enhance the bioavailability (BA), stability, and targeted delivery of therapeutic agents. Current advancements in nanotechnology have resulted in the development of a range of NPs, including solid lipid nanoparticles, polymeric NPs, Hybrid NPs, and Metallic Nanoparticles, which hold promise for TB treatment.
Methods:
This review compiles and analyzes data from more than 100 studies on the use of NPs in TB from the past 10 years (January 1, 2015, to January 1, 2025). This review was conducted using scientific databases like PubMed, ScienceDirect, Google Scholar, NCBI, Google Patent, clinicaltrials.gov, etc. Result: The review found that NPs significantly improve drug delivery to TB-infected tissues, leading to enhanced therapeutic outcomes.
Conclusion:
Nanoparticles represent a cutting-edge therapeutic strategy with the potential to revolutionize the treatment of TB. The enhanced efficacy, specificity, and reduced toxicity of NPs-based DDs.
More Related Videos
11:52Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
11:19Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
Published on: May 10, 2018
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:24Microbial Corrosion